Jared Barsky
Examiner (ID: 13656, Phone: (571)272-2795 , Office: P/1628 )
Most Active Art Unit | 1628 |
Art Unit(s) | 1628 |
Total Applications | 964 |
Issued Applications | 443 |
Pending Applications | 93 |
Abandoned Applications | 428 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9463249
[patent_doc_number] => 20140127676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'ISOLATED LIVER STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/152673
[patent_app_country] => US
[patent_app_date] => 2014-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28521
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14152673
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/152673 | Method of in vitro toxicity testing using isolated liver stem cells | Jan 9, 2014 | Issued |
Array
(
[id] => 9463279
[patent_doc_number] => 20140127706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY'
[patent_app_type] => utility
[patent_app_number] => 14/136638
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4541
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14136638
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/136638 | METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY | Dec 19, 2013 | Abandoned |
Array
(
[id] => 9479811
[patent_doc_number] => 20140137275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'HYBRID LIGHT CHAIN MICE'
[patent_app_type] => utility
[patent_app_number] => 14/132412
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26428
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14132412
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/132412 | Hybrid light chain mice | Dec 17, 2013 | Issued |
Array
(
[id] => 9616703
[patent_doc_number] => 20140206558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'SYSTEM FOR PRODUCTION OF ANTIBODIES AND THEIR DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/094109
[patent_app_country] => US
[patent_app_date] => 2013-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26669
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14094109
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/094109 | System for production of antibodies and their derivatives | Dec 1, 2013 | Issued |
Array
(
[id] => 9958207
[patent_doc_number] => 09006413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'PCP2 mini-promoters'
[patent_app_type] => utility
[patent_app_number] => 14/086817
[patent_app_country] => US
[patent_app_date] => 2013-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9263
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14086817
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/086817 | PCP2 mini-promoters | Nov 20, 2013 | Issued |
Array
(
[id] => 14356379
[patent_doc_number] => 10299467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Animal model for type 2 diabetes and obesity
[patent_app_type] => utility
[patent_app_number] => 14/439609
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 40
[patent_no_of_words] => 20529
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439609
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/439609 | Animal model for type 2 diabetes and obesity | Oct 30, 2013 | Issued |
Array
(
[id] => 10435008
[patent_doc_number] => 20150320020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'FIBROTIC NON-HUMAN ANIMAL, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/439885
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10140
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439885
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/439885 | Fibrotic non-human animal, and use thereof | Oct 30, 2013 | Issued |
Array
(
[id] => 10213961
[patent_doc_number] => 20150098954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'Compositions and Methods Related to CRISPR Targeting'
[patent_app_type] => utility
[patent_app_number] => 14/048283
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8552
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048283
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/048283 | Compositions and Methods Related to CRISPR Targeting | Oct 7, 2013 | Abandoned |
Array
(
[id] => 9383405
[patent_doc_number] => 20140086886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'Stem Cell, Precursor Cell, or Target Cell-Based Treatment of Multi-Organ Failure and Renal Dysfunction'
[patent_app_type] => utility
[patent_app_number] => 14/030859
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13933
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14030859
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/030859 | Stem Cell, Precursor Cell, or Target Cell-Based Treatment of Multi-Organ Failure and Renal Dysfunction | Sep 17, 2013 | Abandoned |
Array
(
[id] => 9294045
[patent_doc_number] => 20140037679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'Immunization of avians by administration of non-replicating vectored vaccines'
[patent_app_type] => utility
[patent_app_number] => 14/020024
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27913
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14020024
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/020024 | Immunization of avians by administration of non-replicating vectored vaccines | Sep 5, 2013 | Issued |
Array
(
[id] => 10323618
[patent_doc_number] => 20150208622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/420318
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 18826
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420318
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420318 | Genetically modified non-human animals and methods of use thereof | Sep 5, 2013 | Issued |
Array
(
[id] => 9263366
[patent_doc_number] => 20130345295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'TARGETED ONCOLYTIC ADENOVIRUS FOR TREATMENT OF HUMAN TUMORS, CONSTRCUTION METHOD AND APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/016149
[patent_app_country] => US
[patent_app_date] => 2013-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 3919
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14016149
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/016149 | TARGETED ONCOLYTIC ADENOVIRUS FOR TREATMENT OF HUMAN TUMORS, CONSTRCUTION METHOD AND APPLICATION THEREOF | Sep 1, 2013 | Abandoned |
Array
(
[id] => 10333226
[patent_doc_number] => 20150218230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'METHODS FOR MODULATING TAL SPECIFICITY'
[patent_app_type] => utility
[patent_app_number] => 14/424757
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32524
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424757
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/424757 | Methods for modulating TAL specificity | Aug 29, 2013 | Issued |
Array
(
[id] => 13746749
[patent_doc_number] => 10166299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-01
[patent_title] => AAV mediated aquaporin gene transfer to treat Sjogren's syndrome
[patent_app_type] => utility
[patent_app_number] => 14/423774
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 13698
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423774
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/423774 | AAV mediated aquaporin gene transfer to treat Sjogren's syndrome | Aug 29, 2013 | Issued |
13/975217 | ANIMAL MODELS FOR CANCER AND USES THEREOF | Aug 22, 2013 | Abandoned |
13/975179 | ANIMAL MODELS OF AGE-RELATED DISORDERS AND AGE-SENSITIVE TRAITS ASSOCIATED WITH SENESCENCE-INDUCING STIMULI AND USES THEREOF | Aug 22, 2013 | Abandoned |
Array
(
[id] => 13127485
[patent_doc_number] => 10081663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Affinity maturated T cell receptors and use thereof
[patent_app_type] => utility
[patent_app_number] => 13/958277
[patent_app_country] => US
[patent_app_date] => 2013-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 55
[patent_no_of_words] => 20903
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13958277
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/958277 | Affinity maturated T cell receptors and use thereof | Aug 1, 2013 | Issued |
Array
(
[id] => 10290959
[patent_doc_number] => 20150175958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'CELL LINE DERIVED FROM THREAD-SAIL FILEFISH (STEPHANOLEPIS CIRRHIFER)'
[patent_app_type] => utility
[patent_app_number] => 14/418781
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 16444
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418781
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/418781 | Cell line derived from thread-sail filefish (Stephanolepis cirrhifer) | Jul 29, 2013 | Issued |
Array
(
[id] => 9148313
[patent_doc_number] => 20130302836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'COMMON LIGHT CHAIN MOUSE'
[patent_app_type] => utility
[patent_app_number] => 13/948818
[patent_app_country] => US
[patent_app_date] => 2013-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21712
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13948818
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/948818 | COMMON LIGHT CHAIN MOUSE | Jul 22, 2013 | Abandoned |
Array
(
[id] => 13196477
[patent_doc_number] => 10113148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Method for obtaining monocytes or NK cells
[patent_app_type] => utility
[patent_app_number] => 14/414377
[patent_app_country] => US
[patent_app_date] => 2013-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 6679
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414377
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/414377 | Method for obtaining monocytes or NK cells | Jul 9, 2013 | Issued |